Drug intelligence / Profile preview

SWAP-70 short hairpin RNA

Development stage
Preclinical
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intraperitoneal
01

Overview

SWAP-70 short hairpin RNA is an RNA interference (RNAi) based therapeutic agent designed to silence the expression of the Switch-associated protein 70 (SWAP-70). SWAP-70 is a multifunctional signal transduction molecule and guanine nucleotide exchange factor (GEF) primarily expressed in B cells, where it regulates critical processes such as polarization, directed migration, and adhesion to endothelial cells. In the context of autoimmune diseases like Multiple Sclerosis (MS), SWAP-70 is implicated in the pathogenic activation and homing of B cells to the central nervous system. By utilizing shRNA to knock down SWAP-70 levels, this therapy aims to modulate B-cell-mediated immune responses and reduce neuroinflammation. Preclinical research using the experimental autoimmune encephalomyelitis (EAE) model has demonstrated that acquired inhibition of SWAP-70 can alter immune cell subsets and ameliorate disease progression.

Other names
SWAP-70 shRNASWAP70 shRNASWAP 70 shRNAshSWAP-70shSWAP70shSWAP 70shRNA targeting SWAP-70
02

Targets

SWAP70 (Switch-associated protein 70)

Beyond the preview

Go deeper on SWAP-70 short hairpin RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SWAP-70 short hairpin RNA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call